You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Comprised of the authoritative work of international experts, this fully-updated second edition of Scleroderma builds upon the well-regarded approach in the first edition to provide integrated, concise, and up-to-date synthesis of current concepts of pathogenesis and modern approaches to management of systemic sclerosis (scleroderma). With a multidisciplinary approach to comprehensive care, this book is easily accessible for health care professionals in many fields. The new edition includes extensive updated material based on major developments in the field, with new chapters on personalized medicine, cancer complications, global perspectives on scleroderma, and more. It presents a succinct and thoughtful synthesis of current pathomechanistic concepts, providing a valuable reference tool for basic and translational investigators working in the field. Scleroderma: From Pathogenesis to Comprehensive Management serves as an essential, all-inclusive resource for rheumatologists, pulmonologists, cardiologists, gastroenterologists, nephrologists and all those involved in the care of scleroderma patients.
Raynaud’s Phenomenon: A Guide to Pathogenesis and Treatment comprehensively reviews the understanding of a disorder that continues to challenge primary care clinicians and specialists alike. In the last decade, there have been important advances not only in understanding the pathophysiology of Raynaud’s Phenomenon (RP), but also in developing diagnostic methods and effective drug and non-drug therapies. Thoroughly discussing the various manifestations of RP, including childhood RP, RP secondary to connective tissue disease, and a variety of other associated disorders that include vascular perturbation that mimics RP, this title provides a wealth of new information available on normal and...
Scleroderma is unique among our rheumatic diseases both in its clinical expression and its resistance to recovery when using our usual anti-inflammatory medications. The reason for this difference is now becoming apparent as the biology of the scleroderma process is better understood. It is now recognized that the disease expression is quite heterogeneous and that several different clinical but distinct phenotypes exists. This issue of Rheumatic Disease Clinics provides a concise update of developments in this area of study and covers topics such as vascular disease in scleroderma, diagnosis, management of the disease, genetics, novel treatments, scleroderma-like disorders, and its effect on the heart and lungs.
This essential resource presents the most up-to-date information on scleroderma. A clear and concise synthesis of current concepts in pathogenesis and modern approaches to management, this book is comprised of the authoritative work of international experts. With an integrated multidisciplinary approach to comprehensive care, this book is easily accessible for health care professionals in many fields. It is a valuable resource for rheumatologists, pulmonologists, cardiologists, gastroenterologists, nephrologists and all those involved in the care of scleroderma patients.
None
The first book dedicated explicitly to the care of elderly patients with rheumatic diseases, this comprehensive resource is a practical guide for navigating the medical concerns of these complex patients. While patients over 65 years of age comprise roughly 15% of the population, they consume about 50% of rheumatology resources. This book presents current clinical practices with an eye toward achieving economically sustainable models of care. The world’s leading authorities have come together to cover the full spectrum of rheumatic diseases, the immune system in aging, and ultrasound evaluation and arthrocentesis. The book also addresses the milieu of co-morbidities that the clinician may ...
Helps you to better understand scientific underpinnings of rheumatic diseases, so that you can better manage your patients.
Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. Hardening of the skin is one of the most visible manifestations of the disease. It's estimated that about 300,000 Americans have scleroderma. About one third of those people have the systemic form of scleroderma. Since scleroderma presents with symptoms similar to other autoimmune diseases, diagnosis is difficult. This issue will cover: The Genetic Basis of SSc: Genetics, Epigenetics, Mechanisms of Pathogenesis - linking fibrosis, vasculopathy and immune dysregulation, The Role of Autoantibodies in Diagnosis and Prognosis/survival; Managing Raynaud's phenomenon and ischemic ulcers, managing SSc Lung Disease, Monitoring for and Managing Pulmonary Arterial Hypertension, and many more!
A comprehensive review of inflammatory syndromes and diseases that affect the blood vessels, this volume draws upon authors from all over the world to present informed discussions on all types of vasculitis and related conditions.
This is a new edition of the successful textbook providing updated, detailed information on clinical, epidemiologic, pathophysiologic and therapeutic aspects of common and rare forms of vasculitis. New chapters include pathology of vasculitis, autoantibodies, animal models of vasculitis and PET scanning. Separate sections are devoted to basic science, clinical manifestations commonly seen in vasculitis, imaging and perpcutaneous interventions, individual diseases and syndromes as well as conditions which can mimic vasculitis. Subsumed under clinical manifestations are chapters, some new, which deal with skin, oral ulcers, eyes, cardiopulmonary system, nervous system, the gastrointestinal track, kidney and digital ischemia and Raynaud's phenomenon. Other chapters address diagnostic approaches to adults and to children with suspected vasculitis, as well as assessment of disease activity and damage. Individual chapters are written by authorities from throughout the world.